InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced ...

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the ...

A new set of bills moving through the Michigan State Senate could soon establish new protections for renters.

Arbor Realty: Dividend Unlikely To Recover After 2025 As Multifamily Outlook Worsens May 17, 2025 9:37 AM ET Arbor Realty Trust, Inc. (ABR) Stock ABR 64 Comments Harrison Schwartz 16.42K Follower s ...

Arbor Realty Trust axed its dividend by 30 percent after reporting a plunge in first-quarter profits and projecting the distress hurting earnings was far from over.

A combination of crippling tariffs and less-than-great headlines tarnished Arbor Realty Trust’s first quarter of 2025 The nationwide multifamily REIT and direct housing lender announced during ...

JPMorgan analyst Richard Shane lowered the firm’s price target on Arbor Realty (ABR) to $10.50 from $11.50 and keeps an Underweight rating on the shares as part of a Q1 preview for the mortgage ...

Where did all of the dog's food go? And where is that grocery receipt? You'd be surprised at the hoarding powers of mice.

Arbor Realty Trust, Inc. (NYSE:ABR – Get Free Report) was the target of some unusual options trading activity on Thursday. Stock traders acquired 30,722 put options on the company. This ...

On Tuesday, Keefe, Bruyette & Woods made a revision to the price target on Arbor Realty Trust (NYSE: ABR) shares, lowering it to $12.00 from the previous $13.50, while the firm maintained a Market ...

On Tuesday, Keefe, Bruyette & Woods made a revision to the price target on Arbor Realty Trust (NYSE: ABR) shares, lowering it to $12.00 from the previous $13.50, while the firm maintained a Market ...

Keefe Bruyette analyst Jade Rahmani lowered the firm’s price target on Arbor Realty (ABR) to $12 from $13.50 and keeps a Market Perform rating on the shares. Fourth quarter challenges continued ...